Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 31 Pancreatic Neoplasms 8 Colorectal Neoplasms 7 Biliary Tract Neoplasms 5 Neoplasm Metastasis 4 Breast Neoplasms 3 Recurrence 2 Gastrointestinal Neoplasms 2 Carcinoma, Hepatocellular 2 Advanced Gastric Cancer 2 Rectal Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Liver Diseases 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Bile Duct Neoplasms 1 Advanced Solid Tumors 1 Advanced Biliary Tract Cancer 1

Interventions

Cisplatin 258 Radiotherapy 193 Cetuximab 151 pembrolizumab 123 Docetaxel 97 Fluorouracil 92 Carboplatin 80 Paclitaxel 78 Radiotherapy, Intensity-Modulated 72 Surveys and Questionnaires 46 Nivolumab 42 Drug Therapy 34 Radiation 33 Blood Specimen Collection 27 Erlotinib Hydrochloride 26 Gemcitabine 25 Immunohistochemistry 22 Gefitinib 22 Cyclophosphamide 22 Surgical Procedures, Operative 21 Standard of Care 20 durvalumab 19 Pemetrexed 19 Magnetic Resonance Spectroscopy 19 Radiosurgery 17 Capecitabine 17 Chemotherapy, Adjuvant 16 Celecoxib 16 Biopsy 16 atezolizumab 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × titanium silicide × Clear all

NCT01645748 2012-07-20

TPSHNSCC

Chonnam National University Hospital

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡